期刊
ECANCERMEDICALSCIENCE
卷 11, 期 -, 页码 -出版社
eCancer Global Foundation
DOI: 10.3332/ecancer.2017.723
关键词
ovarian cancer; metronomic chemotherapy; cyclophosphamide
类别
资金
- Roemmers Foundation
- Ministry of Science, Technology and Innovation of Santa Fe, Argentine
Ovarian cancer (OC) is the leading cause of death from gynaecological cancer. It is extremely hard to diagnose in the early stages and around 70% of patients present with advanced disease. Metronomic chemotherapy (MCT) is described as the chronic administration of, generally low, equally spaced, doses of chemotherapeutic drugs with therapeutic efficacy and low toxicity. This is an effective and low-cost way to treat several types of tumours, including ovarian cancer. Here, we present six cases of advanced ovarian cancer treated with MCT with low doses of cyclophosphamide, which showed clinical response and stable disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据